Alliance of U.S. Startups and Inventors for Jobs
@USIJorg
Coalition of startups, inventors, investors, and entrepreneurs advocating for a reliable and effective U.S. patent system.
In a new policy agenda, @USIJorg outlines next steps for lawmakers on how to boost innovation and beat China. Check it out: buff.ly/41ak3QM
The ability to patent new developments on existing technology gives inventors the security they need to take risks and improve their product. That's not "product hopping" -- that's the U.S.'s system of IP protections at work. Get the facts here: buff.ly/25rSZSA
Check out our latest blog! In it, we unpack some of the core patent myths underlying two anti-IP bills -- "Product Hopping" and "Patent Thickets" -- and why they misrepresent reality. 🔗 c4ip.org/why-c4ip-oppos…
ICYMI: Our new white paper analyzes the Trump administration's proposed MFN prescription drug pricing model. Check it out: buff.ly/EqmRSTd
Great webinar on PERA! Learn more and register 👇
📢 On Aug. 13 at 12 PM ET, join @FedSoc for a webinar on the Patent Eligibility Restoration Act. The event will feature remarks from C4IP's Jamie Simpson and Judge Kathleen O'Malley, alongside other industry experts. Register: fedsoc.org/events/the-pat…
"Fourteen years of abuse of inventors has caused a significant decline in the number of startups willing to challenge large incumbents as emerging competitors, with devastating impact on competition and the kinds of innovation that only small companies and individuals can provide…
The U.S. needs a strong patent system to remain a global leader. Learn why: buff.ly/ZAyGqNh
That's the power of IP 💡
IP-intensive industries are essential to the U.S. economy 📈 The @USPTO found that IP-intensive industries make up over 40% of the U.S. economy and support around 63 million jobs. Learn more about the vital role that IP plays in driving U.S. economic growth:…
DYK that academic tech transfer at U.S. universities resulted in more than 500,000 inventions disclosed from 1996 to 2020? That's the power of the Bayh-Dole Act. Learn more in a new study from @ITIFdc: buff.ly/sw9mA41
Myth: Patent "thickets" deter competition and hinder generics. Fact: A recent @USPTO study debunks the myth of widespread pharmaceutical "patent thicketing." Learn more in @Law360: buff.ly/ADblvSG
.@USIJorg filed an amicus brief last week, defending USPTO discretion and inventor protections. Check it out: buff.ly/Hq7NTJk
Our new white paper outlines how President Trump's proposed MFN policy would harm innovation, particularly for small biotech companies, and offers alternatives to lawmakers. Give it a read: buff.ly/EqmRSTd
The founding fathers recognized that the new and free society they were enshrining needed an incentive to take risks and an assurance to protect risk-takers. Learn more: buff.ly/ZAyGqNh
It was great to hear from such a well-versed panel of experts and keynote speaker @RepDeborahRoss at @ITIFdc's event today! Watch the full discussion here: buff.ly/QnuAQAm
❌ Myth: Weakening protections for follow-on patents would benefit patients. ✅ Fact: Nine in 10 U.S. prescriptions are already filled with generics. Weakening follow-on patents would only chill the development of safer, more convenient, or more effective alternatives. Learn…
Patent "evergreening" is a myth. Learn more, with help from @Council4IP: buff.ly/Vts2YId
Ever heard of “The Fresh Coat”? It’s a classic #BigPharma tactic, also known as #evergreening, used to block generic drug competition and keep prices sky-high. 💡 See more moves in Big Pharma’s Patent Playbook.
💡💡💡
"The success of Bayh-Dole depends on a robust and stable patent system..." Learn more about why strong patent rights -- and legislation that upholds our IP system -- are essential to U.S. innovation: buff.ly/4dpibBT
Great event later today for those in the D.C. area 👇
🚨 Happening today! Join us for "Anatomy of a Movie: A Complete Unknown" from 3:00–4:30 PM ET. Attendees will hear directly from industry experts, producers, executives, and others who helped bring the movie to life. 📍 Longworth House Office Building, Room 1539 🎟️ To…
Does your startup, research institution, or investment strategy rely on strong and enforceable patents? If you answered “yes,” consider joining USIJ! More info here: buff.ly/bAfXc2f
Last year, @USIJorg filed an amicus brief in support of ParkerVision, Inc. Learn more about our support for inventors: buff.ly/8jT7ECz